National Key Research and
Development Program of China (2021YFC2009303), Project of
Health Commission of Sichuan Province (21PJ041), the Key
Research Development Support Plan of Chengdu Science and Technology
Bureau (2022-YF05-01568-SN), the National Natural Science
Foundation of China (Grant No. 82170432) and programs from
Science and Technology Department of Sichuan Province (Grant
No. 2020YFSY0024).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|3 区医学
小类|3 区外科
最新[2023]版:
大类|3 区医学
小类|3 区外科
第一作者:
第一作者机构:[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China[*1]Department of Urology and Pelvic surgery, West China School of Public Health and West China, Fourth Hospital, Sichuan University, Chengdu, Sichuan, China
推荐引用方式(GB/T 7714):
Wu Ruicheng,Li Dengxiong,Feng Dechao,et al.Transmembrane protein 132A (TMEM132A) predicts overall survival for bladder cancer patients[J].Asian journal of surgery.2023,doi:10.1016/j.asjsur.2023.03.116.
APA:
Wu Ruicheng,Li Dengxiong,Feng Dechao&Han Ping.(2023).Transmembrane protein 132A (TMEM132A) predicts overall survival for bladder cancer patients.Asian journal of surgery,,
MLA:
Wu Ruicheng,et al."Transmembrane protein 132A (TMEM132A) predicts overall survival for bladder cancer patients".Asian journal of surgery .(2023)